Evaluate the Efficacy and Safety of HL-1186 in Patients With Diabetic Peripheral Neuropathic Pain
Clinical trial NCT07159243 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07159243
- Sponsor
- Shanghai Yidian Pharmaceutical Technology Development Co., Ltd.
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-09-01
- Primary completion
- 2026-10-01
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.